![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Pizzocolo Cecilia Castagna Antonella Lazzarin Adriano
Publisher: Future Medicine
ISSN: 1746-0794
Source: Future Virology, Vol.6, Iss.5, 2011-05, pp. : 571-580
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives
Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Heterocyclic HIV-Protease Inhibitors
Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kuhnert Maren Diederich Wibke E.
PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prodrugs of HIV Protease Inhibitors
Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. :